07:52:44 EDT Wed 08 May 2024
Enter Symbol
or Name
USA
CA



BioSyent Inc
Symbol RX
Shares Issued 12,023,109
Close 2023-12-12 C$ 8.62
Market Cap C$ 103,639,200
Recent Sedar Documents

BioSyent normal course issuer bid

2023-12-13 16:12 ET - Normal Course Issuer Bid

The TSX Venture Exchange has been advised by the company that pursuant to a notice of intention to make a normal course issuer bid dated Dec. 12, 2023, it may repurchase for cancellation, up to 650,000 common shares in its own capital stock. The purchases are to be made through the facilities of TSX Venture Exchange or other recognized marketplaces during the period Dec. 19, 2023, to Dec. 18, 2024. Purchases pursuant to the bid will be made by Raymond James Ltd. on behalf of the company.

© 2024 Canjex Publishing Ltd. All rights reserved.